{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T18:33:16Z","timestamp":1770834796997,"version":"3.50.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T00:00:00Z","timestamp":1294185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12016-010-8235-x","type":"journal-article","created":{"date-parts":[[2011,1,4]],"date-time":"2011-01-04T03:31:17Z","timestamp":1294111877000},"page":"298-308","source":"Crossref","is-referenced-by-count":41,"title":["The Diagnostic and Clinical Significance of Anti-Muscarinic Receptor Autoantibodies"],"prefix":"10.1007","volume":"42","author":[{"given":"Udi","family":"Nussinovitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,5]]},"reference":[{"key":"8235_CR1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1136\/hrt.2010.195255","volume":"96","author":"U Nussinovitch","year":"2010","unstructured":"Nussinovitch U, Shoenfeld Y (2010) Anti-troponin autoantibodies and the cardiovascular system. Heart 96:1518\u20131524","journal-title":"Heart"},{"key":"8235_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00005-009-0013-1","volume":"57","author":"U Nussinovitch","year":"2009","unstructured":"Nussinovitch U, Shoenfeld Y (2009) Autoimmunity and heart diseases: pathogenesis and diagnostic criteria. Arch Immunol Ther Exp (Warsz) 57:95\u2013104","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"8235_CR3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","volume":"7","author":"U Nussinovitch","year":"2008","unstructured":"Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin\u2014indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7:445\u2013452","journal-title":"Autoimmun Rev"},{"key":"8235_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-60327-285-8_67","volume-title":"Diagnostic criteria in autoimmune diseases","author":"U Nussinovitch","year":"2008","unstructured":"Nussinovitch U, Shoenfeld Y (2008) Autoimmune dilated cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic criteria in autoimmune diseases. The Humana Press Inc, New Jersey, pp 367\u2013372"},{"key":"8235_CR5","doi-asserted-by":"crossref","unstructured":"Nussinovitch U, Shoenfeld Y (2010) Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev doi: 10.1111\/j.1365-2249.2010.04265.x","DOI":"10.1111\/j.1365-2249.2010.04265.x"},{"issue":"173\u2013176","key":"8235_CR6","first-page":"210","volume":"148","author":"U Nussinovitch","year":"2009","unstructured":"Nussinovitch U, Shoenfeld Y (2009) Autoimmune mechanisms in cardiovascular diseases. Harefuah 148(173\u2013176):210","journal-title":"Harefuah"},{"key":"8235_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijcard.2006.05.008","volume":"112","author":"R Jahns","year":"2006","unstructured":"Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7\u201314","journal-title":"Int J Cardiol"},{"key":"8235_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.autrev.2008.07.024","volume":"8","author":"A Brucato","year":"2008","unstructured":"Brucato A, Maestroni S, Cumetti D et al (2008) Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev 8:44\u201347","journal-title":"Autoimmun Rev"},{"key":"8235_CR9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.autrev.2007.11.021","volume":"7","author":"ME Gershwin","year":"2008","unstructured":"Gershwin ME (2008) The mosaic of autoimmunity. Autoimmun Rev 7:161\u2013163","journal-title":"Autoimmun Rev"},{"key":"8235_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.autrev.2007.11.007","volume":"7","author":"L Stojanovich","year":"2008","unstructured":"Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209\u2013213","journal-title":"Autoimmun Rev"},{"key":"8235_CR11","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1096\/fasebj.13.14.2015","volume":"13","author":"FC Retondaro","year":"1999","unstructured":"Retondaro FC, Dos Santos Costa PC, Pedrosa RC, Kurtenbach E (1999) Presence of antibodies against the third intracellular loop of the M2 muscarinic receptor in the sera of chronic chagasic patients. FASEB J 13:2015\u20132020","journal-title":"FASEB J"},{"key":"8235_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2007.06.001","volume":"7","author":"N Gleicher","year":"2007","unstructured":"Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity? Autoimmun Rev 7:42\u201345","journal-title":"Autoimmun Rev"},{"key":"8235_CR13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.autrev.2008.06.007","volume":"7","author":"MJ Fritzler","year":"2008","unstructured":"Fritzler MJ (2008) Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 7:616\u2013620","journal-title":"Autoimmun Rev"},{"key":"8235_CR14","first-page":"13","volume":"10","author":"Y Shoenfeld","year":"2008","unstructured":"Shoenfeld Y, Blank M, Abu-Shakra M et al (2008) The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases\u20132008. Isr Med Assoc J 10:13\u201319","journal-title":"Isr Med Assoc J"},{"key":"8235_CR15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/08916930802031603","volume":"41","author":"R Jahns","year":"2008","unstructured":"Jahns R, Boivin V, Schwarzbach V, Ertl G, Lohse MJ (2008) Pathological autoantibodies in cardiomyopathy. Autoimmunity 41:454\u2013461","journal-title":"Autoimmunity"},{"key":"8235_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/eurjhf\/hfq072","volume":"12","author":"N Deubner","year":"2010","unstructured":"Deubner N, Berliner D, Schlipp A et al (2010) Cardiac beta1-adrenoceptor autoantibodies in human heart disease: rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Eur J Heart Fail 12:753\u2013762","journal-title":"Eur J Heart Fail"},{"key":"8235_CR17","doi-asserted-by":"crossref","unstructured":"Kaya Z, Katus HA, Rose NR (2009) Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol","DOI":"10.1016\/j.clim.2009.04.008"},{"key":"8235_CR18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.04.077","volume":"117","author":"H Shmilovich","year":"2007","unstructured":"Shmilovich H, Danon A, Binah O et al (2007) Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 117:198\u2013203","journal-title":"Int J Cardiol"},{"key":"8235_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-007-0686-8","volume":"103","author":"PE Lazzerini","year":"2008","unstructured":"Lazzerini PE, Capecchi PL, Guideri F et al (2008) Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications. Basic Res Cardiol 103:1\u201311","journal-title":"Basic Res Cardiol"},{"key":"8235_CR20","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1096\/fj.04-3042com","volume":"19","author":"JC Peter","year":"2005","unstructured":"Peter JC, Tugler J, Eftekhari P, Maurice D, Hoebeke J, Roegel JC (2005) Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 19:943\u2013949","journal-title":"FASEB J"},{"key":"8235_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/42.3.8308250","volume":"42","author":"M Fu","year":"1994","unstructured":"Fu M, Schulze W, Wolf WP, Hjalmarson A, Hoebeke J (1994) Immunocytochemical localization of M2 muscarinic receptors in rat ventricles with anti-peptide antibodies. J Histochem Cytochem 42:337\u2013343","journal-title":"J Histochem Cytochem"},{"key":"8235_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0167-5273(96)02589-2","volume":"54","author":"ML Fu","year":"1996","unstructured":"Fu ML (1996) Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy. Int J Cardiol 54:127\u2013135","journal-title":"Int J Cardiol"},{"key":"8235_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-2828(87)80544-8","volume":"19","author":"JW Fleming","year":"1987","unstructured":"Fleming JW, Strawbridge RA, Watanabe AM (1987) Muscarinic receptor regulation of cardiac adenylate cyclase activity. J Mol Cell Cardiol 19:47\u201361","journal-title":"J Mol Cell Cardiol"},{"key":"8235_CR24","first-page":"2618","volume":"43","author":"AM Watanabe","year":"1984","unstructured":"Watanabe AM, Lindemann JP, Fleming JW (1984) Mechanisms of muscarinic modulation of protein phosphorylation in intact ventricles. Fed Proc 43:2618\u20132623","journal-title":"Fed Proc"},{"key":"8235_CR25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3181\/00379727-195-43155","volume":"195","author":"C Paaerez Leiros","year":"1990","unstructured":"Paaerez Leiros C, Sterin-Borda L, Cossio P, Borda ES (1990) Muscarinic cholinergic antibody in experimental autoimmune myocarditis regulates cardiac function. Proc Soc Exp Biol Med 195:356\u2013363","journal-title":"Proc Soc Exp Biol Med"},{"key":"8235_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0090-1229(05)80010-8","volume":"61","author":"L Sterin-Borda","year":"1991","unstructured":"Sterin-Borda L, Gorelik G, Borda ES (1991) Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals. Clin Immunol Immunopathol 61:387\u2013397","journal-title":"Clin Immunol Immunopathol"},{"key":"8235_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0090-1229(90)90098-B","volume":"55","author":"G Gorelik","year":"1990","unstructured":"Gorelik G, Genaro AM, Sterin-Borda L, Gonzalez Cappa S, Borda ES (1990) Antibodies bind and activate beta adrenergic and cholinergic lymphocyte receptors in Chagas\u2019 disease. Clin Immunol Immunopathol 55:221\u2013236","journal-title":"Clin Immunol Immunopathol"},{"key":"8235_CR28","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1172\/JCI116416","volume":"91","author":"LX Fu","year":"1993","unstructured":"Fu LX, Magnusson Y, Bergh CH et al (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91:1964\u20131968","journal-title":"J Clin Invest"},{"key":"8235_CR29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.yjmcc.2004.12.009","volume":"38","author":"LE Gimenez","year":"2005","unstructured":"Gimenez LE, Hernandez CC, Mattos EC et al (2005) DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice. J Mol Cell Cardiol 38:703\u2013714","journal-title":"J Mol Cell Cardiol"},{"key":"8235_CR30","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1074\/jbc.272.20.12989","volume":"272","author":"CP Leiros","year":"1997","unstructured":"Leiros CP, Sterin-Borda L, Borda ES, Goin JC, Hosey MM (1997) Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas\u2019 disease. J Biol Chem 272:12989\u201312993","journal-title":"J Biol Chem"},{"key":"8235_CR31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/clin.1994.1101","volume":"72","author":"ML Fu","year":"1994","unstructured":"Fu ML, Hoebeke J, Matsui S et al (1994) Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 72:15\u201320","journal-title":"Clin Immunol Immunopathol"},{"key":"8235_CR32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000149151","volume":"112","author":"M Fu","year":"2009","unstructured":"Fu M (2009) Autoantibodies in atrial fibrillation: actors, biomarkers or bystanders? How far have we come? Cardiology 112:178\u2013179","journal-title":"Cardiology"},{"key":"8235_CR33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ehj.2004.05.012","volume":"25","author":"A Baba","year":"2004","unstructured":"Baba A, Yoshikawa T, Fukuda Y et al (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 25:1108\u20131115","journal-title":"Eur Heart J"},{"key":"8235_CR34","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1191\/0961203305lu2193oa","volume":"14","author":"AL Caforio","year":"2005","unstructured":"Caforio AL, Daliento L, Angelini A et al (2005) Autoimmune myocarditis and dilated cardiomyopathy: focus on cardiac autoantibodies. Lupus 14:652\u2013655","journal-title":"Lupus"},{"key":"8235_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08916939908995971","volume":"29","author":"HR Liu","year":"1999","unstructured":"Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML (1999) Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29:43\u201351","journal-title":"Autoimmunity"},{"key":"8235_CR36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000149152","volume":"112","author":"CM Hong","year":"2009","unstructured":"Hong CM, Zheng QS, Liu XT, Shang FJ, Wang HT, Jiang WR (2009) Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo. Cardiology 112:180\u2013187","journal-title":"Cardiology"},{"key":"8235_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01827430","volume":"4","author":"C Perez Leiros","year":"1994","unstructured":"Perez Leiros C, Goren N, Sterin-Borda L, Lustig L, Borda E (1994) Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies. Clin Auton Res 4:249\u2013255","journal-title":"Clin Auton Res"},{"key":"8235_CR38","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0024-3205(98)00589-X","volume":"64","author":"G Wallukat","year":"1999","unstructured":"Wallukat G, Fu HM, Matsui S, Hjalmarson A, Fu ML (1999) Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects. Life Sci 64:465\u2013469","journal-title":"Life Sci"},{"key":"8235_CR39","first-page":"25","volume":"3","author":"WZ Wang","year":"1996","unstructured":"Wang WZ, Zhao RR, Wu BW et al (1996) Effects of anti-peptide antibodies against human M2 muscarinic receptors on cardiac function in rats in vivo. Blood Press Suppl 3:25\u201327","journal-title":"Blood Press Suppl"},{"key":"8235_CR40","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1096\/fasebj.11.1.9034169","volume":"11","author":"JC Goin","year":"1997","unstructured":"Goin JC, Leiros CP, Borda E, Sterin-Borda L (1997) Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 11:77\u201383","journal-title":"FASEB J"},{"key":"8235_CR41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s000590050017","volume":"25","author":"G Wallukat","year":"2000","unstructured":"Wallukat G, Nissen E, Morwinski R, Muller J (2000) Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 25:261\u2013266","journal-title":"Herz"},{"key":"8235_CR42","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ehj.2004.05.001","volume":"25","author":"D Dobrev","year":"2004","unstructured":"Dobrev D, Christ T, Ravens U (2004) Muscarinic subtype-2 receptor autoantibodies: actors or bystanders in human atrial fibrillation? Eur Heart J 25:1091\u20131092","journal-title":"Eur Heart J"},{"key":"8235_CR43","doi-asserted-by":"crossref","first-page":"C1251","DOI":"10.1152\/ajpcell.2001.281.4.C1251","volume":"281","author":"JH Nascimento","year":"2001","unstructured":"Nascimento JH, Salle L, Hoebeke J, Argibay J, Peineau N (2001) cGMP-mediated inhibition of cardiac L-type Ca(2+) current by a monoclonal antibody against the M(2) ACh receptor. Am J Physiol Cell Physiol 281:C1251\u2013C1258","journal-title":"Am J Physiol Cell Physiol"},{"key":"8235_CR44","first-page":"867","volume":"113","author":"W Wang","year":"2000","unstructured":"Wang W, Guo G, Tang J et al (2000) Stimulatory activity of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic receptors. Chin Med J (Engl) 113:867\u2013871","journal-title":"Chin Med J (Engl)"},{"key":"8235_CR45","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijcard.2008.02.008","volume":"134","author":"S Ganzinelli","year":"2009","unstructured":"Ganzinelli S, Borda E, Joensen L, Sterin-Borda L (2009) Chagasic antibodies induce cardiac COX-2\/iNOS mRNA expression with PGE2\/NO production. Int J Cardiol 134:212\u2013223","journal-title":"Int J Cardiol"},{"key":"8235_CR46","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cardfail.2008.02.016","volume":"14","author":"JM Lappe","year":"2008","unstructured":"Lappe JM, Pelfrey CM, Tang WH (2008) Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail 14:521\u2013530","journal-title":"J Card Fail"},{"key":"8235_CR47","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cardfail.2008.02.009","volume":"14","author":"KH Miettinen","year":"2008","unstructured":"Miettinen KH, Eriksson S, Magga J et al (2008) Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. J Card Fail 14:481\u2013488","journal-title":"J Card Fail"},{"key":"8235_CR48","doi-asserted-by":"crossref","unstructured":"Nussinovitch U, de Carvalho JF, Pereira RM, Shoenfeld Y (2010) Glucocorticoids and the cardiovascular system: state of the art. Curr Pharm Des","DOI":"10.2174\/138161210793797870"},{"key":"8235_CR49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/08916930500314855","volume":"39","author":"S Matsui","year":"2006","unstructured":"Matsui S, Fu M, Hayase M et al (2006) Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID) mice induces cardiomyopathic changes. Autoimmunity 39:121\u2013128","journal-title":"Autoimmunity"},{"key":"8235_CR50","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1253\/circj.CJ-08-1151","volume":"73","author":"T Yoshikawa","year":"2009","unstructured":"Yoshikawa T, Baba A, Nagatomo Y (2009) Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 73:602\u2013607","journal-title":"Circ J"},{"key":"8235_CR51","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardfail.2008.10.027","volume":"15","author":"Y Nagatomo","year":"2009","unstructured":"Nagatomo Y, Yoshikawa T, Kohno T et al (2009) A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 15:224\u2013232","journal-title":"J Card Fail"},{"key":"8235_CR52","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0735-1097(00)00881-0","volume":"36","author":"R Jahns","year":"2000","unstructured":"Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 36:1280\u20131287","journal-title":"J Am Coll Cardiol"},{"key":"8235_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01431-6","volume":"466","author":"Y Staudt","year":"2003","unstructured":"Staudt Y, Mobini R, Fu M, Felix SB, Kuhn JP, Staudt A (2003) Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 466:1\u20136","journal-title":"Eur J Pharmacol"},{"key":"8235_CR54","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1056\/NEJM200211283472220","volume":"347","author":"G Wallukat","year":"2002","unstructured":"Wallukat G, Muller J, Hetzer R (2002) Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:1806","journal-title":"N Engl J Med"},{"key":"8235_CR55","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.103.13.1765","volume":"103","author":"PA Chiale","year":"2001","unstructured":"Chiale PA, Ferrari I, Mahler E et al (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103:1765\u20131771","journal-title":"Circulation"},{"key":"8235_CR56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1006\/jmcc.1996.0307","volume":"29","author":"S Matsui","year":"1997","unstructured":"Matsui S, Fu ML, Katsuda S et al (1997) Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 29:641\u2013655","journal-title":"J Mol Cell Cardiol"},{"key":"8235_CR57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1071-9164(99)90009-X","volume":"5","author":"S Matsui","year":"1999","unstructured":"Matsui S, Fu ML, Hayase M et al (1999) Active immunization of combined beta1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits. J Card Fail 5:246\u2013254","journal-title":"J Card Fail"},{"key":"8235_CR58","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2249.2004.02480.x","volume":"136","author":"E Mahler","year":"2004","unstructured":"Mahler E, Hoebeke J, Levin MJ (2004) Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas\u2019 heart disease. Clin Exp Immunol 136:527\u2013534","journal-title":"Clin Exp Immunol"},{"key":"8235_CR59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijcard.2006.04.053","volume":"117","author":"AL Ribeiro","year":"2007","unstructured":"Ribeiro AL, Gimenez LE, Hernandez CC et al (2007) Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int J Cardiol 117:59\u201363","journal-title":"Int J Cardiol"},{"key":"8235_CR60","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.micinf.2006.06.006","volume":"8","author":"A Talvani","year":"2006","unstructured":"Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM (2006) Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas\u2019 heart disease. Microbes Infect 8:2459\u20132464","journal-title":"Microbes Infect"},{"key":"8235_CR61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijcard.2008.03.030","volume":"135","author":"AL Ribeiro","year":"2009","unstructured":"Ribeiro AL, de Carvalho AC, Lombardi F, Teixeira MM, Rocha MO (2009) Enhanced parasympathetic activity in Chagas disease still stands in need of proof. Int J Cardiol 135:406\u2013408","journal-title":"Int J Cardiol"},{"key":"8235_CR62","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/01.CIR.96.6.2031","volume":"96","author":"SF Oliveira de","year":"1997","unstructured":"de Oliveira SF, Pedrosa RC, Nascimento JH, Campos de Carvalho AC, Masuda MO (1997) Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 96:2031\u20132037","journal-title":"Circulation"},{"key":"8235_CR63","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(05)62226-X","volume":"350","author":"I Ferrari","year":"1997","unstructured":"Ferrari I, Levin MJ, Elizari MV, Rosenbaum MB, Chiale PA (1997) Cholinergic autoantibodies in sinus-node dysfunction. Lancet 350:262\u2013263","journal-title":"Lancet"},{"key":"8235_CR64","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.hrthm.2006.06.011","volume":"3","author":"PA Chiale","year":"2006","unstructured":"Chiale PA, Garro HA, Schmidberg J et al (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. Heart Rhythm 3:1182\u20131186","journal-title":"Heart Rhythm"},{"key":"8235_CR65","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ijcard.2006.03.022","volume":"115","author":"E Medei","year":"2007","unstructured":"Medei E, Pedrosa RC, Benchimol Barbosa PR et al (2007) Human antibodies with muscarinic activity modulate ventricular repolarization: basis for electrical disturbance. Int J Cardiol 115:373\u2013380","journal-title":"Int J Cardiol"},{"key":"8235_CR66","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10067-010-1434-2","volume":"29","author":"N Nussinovitch","year":"2010","unstructured":"Nussinovitch N, Livneh A, Katz K et al (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353\u20131356","journal-title":"Clin Rheumatol"},{"key":"8235_CR67","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00246-009-9419-0","volume":"30","author":"U Nussinovitch","year":"2009","unstructured":"Nussinovitch U, Katz U, Nussinovitch M, Nussinovitch N (2009) Late ventricular potentials and QT dispersion in familial dysautonomia. Pediatr Cardiol 30:747\u2013751","journal-title":"Pediatr Cardiol"},{"key":"8235_CR68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.CIR.101.4.385","volume":"101","author":"J Muller","year":"2000","unstructured":"Muller J, Wallukat G, Dandel M et al (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385\u2013391","journal-title":"Circulation"},{"key":"8235_CR69","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1253\/circj.CJ-09-0748","volume":"74","author":"A Baba","year":"2010","unstructured":"Baba A, Akaishi M, Shimada M et al (2010) Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure. Circ J 74:1372\u20131378","journal-title":"Circ J"},{"key":"8235_CR70","doi-asserted-by":"crossref","unstructured":"Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y (2009) Evidence for the use of intravenous immunoglobulins-A review of the literature. Clin Rev Allergy Immunol","DOI":"10.1007\/s12016-009-8155-9"},{"key":"8235_CR71","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jacc.2009.07.015","volume":"54","author":"S Stavrakis","year":"2009","unstructured":"Stavrakis S, Yu X, Patterson E et al (2009) Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves\u2019 hyperthyroidism. J Am Coll Cardiol 54:1309\u20131316","journal-title":"J Am Coll Cardiol"},{"key":"8235_CR72","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.4049\/jimmunol.157.9.4203","volume":"157","author":"R Elies","year":"1996","unstructured":"Elies R, Ferrari I, Wallukat G et al (1996) Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas\u2019 disease. J Immunol 157:4203\u20134211","journal-title":"J Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8235-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8235-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8235-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T18:36:21Z","timestamp":1685903781000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8235-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,5]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["8235"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8235-x","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,5]]}}}